The French Cochlear Implant Registry (EPIIC) : General indicators
Copyright © 2020. Published by Elsevier Masson SAS..
Cochlear and brainstem implants have been included on the list of reimbursable products (LPPR) in France since March of 2009. The implants were initially inscribed for 5 years, after which an application for renewal with the French National Commission for the Evaluation of Medical Devices and Health Technologies (Commission Nationale d'évaluation des dispositifs médicaux et des technologies de santé - CNEDiMTS) was required [Haute Autorité de santé, 2009]. Upon registration to the list of reimbursable products, the companies and the reference centers for cochlear and brainstem implants were asked to set up a post-registration registry called EPIIC. This article reports the evolution in the EPIIC registry of the general indicators for 5051 patients over the five years from 2012-2016.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:137 Suppl 1 |
|---|---|
| Enthalten in: |
European annals of otorhinolaryngology, head and neck diseases - 137 Suppl 1(2020) vom: 15. Sept., Seite S5-S9 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gauvrit, F [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 08.09.2021 Date Revised 08.09.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.anorl.2020.07.009 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314643281 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314643281 | ||
| 003 | DE-627 | ||
| 005 | 20231225153154.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.anorl.2020.07.009 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1048.xml |
| 035 | |a (DE-627)NLM314643281 | ||
| 035 | |a (NLM)32891589 | ||
| 035 | |a (PII)S1879-7296(20)30175-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gauvrit, F |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The French Cochlear Implant Registry (EPIIC) |b General indicators |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.09.2021 | ||
| 500 | |a Date Revised 08.09.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020. Published by Elsevier Masson SAS. | ||
| 520 | |a Cochlear and brainstem implants have been included on the list of reimbursable products (LPPR) in France since March of 2009. The implants were initially inscribed for 5 years, after which an application for renewal with the French National Commission for the Evaluation of Medical Devices and Health Technologies (Commission Nationale d'évaluation des dispositifs médicaux et des technologies de santé - CNEDiMTS) was required [Haute Autorité de santé, 2009]. Upon registration to the list of reimbursable products, the companies and the reference centers for cochlear and brainstem implants were asked to set up a post-registration registry called EPIIC. This article reports the evolution in the EPIIC registry of the general indicators for 5051 patients over the five years from 2012-2016 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cochlear implant | |
| 650 | 4 | |a Registry | |
| 700 | 1 | |a Risoud, M |e verfasserin |4 aut | |
| 700 | 1 | |a Aubry, K |e verfasserin |4 aut | |
| 700 | 1 | |a Bordure, P |e verfasserin |4 aut | |
| 700 | 1 | |a Bozorg-Grayeli, A |e verfasserin |4 aut | |
| 700 | 1 | |a Deguine, O |e verfasserin |4 aut | |
| 700 | 1 | |a Eyermann, C |e verfasserin |4 aut | |
| 700 | 1 | |a Franco-Vidal, V |e verfasserin |4 aut | |
| 700 | 1 | |a Godey, B |e verfasserin |4 aut | |
| 700 | 1 | |a Guevara, N |e verfasserin |4 aut | |
| 700 | 1 | |a Karkas, A |e verfasserin |4 aut | |
| 700 | 1 | |a Klopp, N |e verfasserin |4 aut | |
| 700 | 1 | |a Labrousse, M |e verfasserin |4 aut | |
| 700 | 1 | |a Lebreton, J-P |e verfasserin |4 aut | |
| 700 | 1 | |a Lerosey, Y |e verfasserin |4 aut | |
| 700 | 1 | |a Lescanne, E |e verfasserin |4 aut | |
| 700 | 1 | |a Loundon, N |e verfasserin |4 aut | |
| 700 | 1 | |a Marianowski, R |e verfasserin |4 aut | |
| 700 | 1 | |a Merklen, F |e verfasserin |4 aut | |
| 700 | 1 | |a Mezouaghi, K |e verfasserin |4 aut | |
| 700 | 1 | |a Mom, T |e verfasserin |4 aut | |
| 700 | 1 | |a Moreau, S |e verfasserin |4 aut | |
| 700 | 1 | |a Mosnier, I |e verfasserin |4 aut | |
| 700 | 1 | |a Noël-Petroff, N |e verfasserin |4 aut | |
| 700 | 1 | |a Parietti, C |e verfasserin |4 aut | |
| 700 | 1 | |a Piller, P |e verfasserin |4 aut | |
| 700 | 1 | |a Poncet, C |e verfasserin |4 aut | |
| 700 | 1 | |a Radafy, E |e verfasserin |4 aut | |
| 700 | 1 | |a Roman, S |e verfasserin |4 aut | |
| 700 | 1 | |a Roux-Vaillard, S |e verfasserin |4 aut | |
| 700 | 1 | |a Schmerber, S |e verfasserin |4 aut | |
| 700 | 1 | |a Tavernier, L |e verfasserin |4 aut | |
| 700 | 1 | |a Truy, E |e verfasserin |4 aut | |
| 700 | 1 | |a Vincent, C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European annals of otorhinolaryngology, head and neck diseases |d 2010 |g 137 Suppl 1(2020) vom: 15. Sept., Seite S5-S9 |w (DE-627)NLM201398648 |x 1879-730X |7 nnns |
| 773 | 1 | 8 | |g volume:137 Suppl 1 |g year:2020 |g day:15 |g month:09 |g pages:S5-S9 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.anorl.2020.07.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 137 Suppl 1 |j 2020 |b 15 |c 09 |h S5-S9 | ||